A. Lozano

发表

Multidisciplinary management of head and neck cancer: First expert consensus using Delphi methodology from the Spanish Society for Head and Neck Cancer (part 2).

F. Esteban, J. Giralt, R. Mesía, 2017, Oral oncology.

Cisplatin, radiation, and amifostine in carcinoma of the uterine cervix.

A. Mohar, G. Calderillo, J. G. De la Garza, 1999, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Adequacy of nutritional support using computed tomography (CT) in patients with head and neck cancer (HNC) during chemo-radiotherapy (CRT)

V. Baracos, R. Mesía, N. Virgili, 2021, European Journal of Clinical Nutrition.

Favorable Biochemical Freedom From Recurrence With Stereotactic Body Radiation Therapy for Intermediate and High-Risk Prostate Cancer: A Single Institutional Experience With Long-Term Follow-Up

A. Hanlon, A. Ricco, R. Lanciano, 2020, Frontiers in Oncology.

Outcomes and computed tomography radiomic features extraction in soft tissue sarcomas treated with neoadjuvant radiation therapy

G. Reynés-Llompart, J. González-Viguera, A. Lozano, 2021, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

Hyperfractionated Radiotherapy: Improvement of Survival in Locally Advanced Nasopharyngeal Carcinoma

R. Mesía, M. Martinez Garcia, J. Germà, 2009, The Annals of otology, rhinology, and laryngology.

Proton Therapy Outcomes for Head and Neck Cutaneous Melanoma: Proton Collaborative Group Analysis

R. Press, J. I. Choi, C. Simone, 2022, International journal of particle therapy.

The potential role of imaging techniques in avoiding neck dissection during salvage surgery after head and neck carcinoma treated with bioradiotherapy

R. Mesía, A. Rovira, J. Viñals, 2021, The Journal of Laryngology & Otology.

S0022215121001900jra 970..975

R. Mesía, A. Rovira, J. Viñals, 2021 .

Salvage surgery after head and neck squamous cell carcinoma treated with bioradiotherapy

R. Mesía, A. Rovira, R. Montal, 2017, Head & neck.

Management of Cutaneous Toxicity and Radiation Dermatitis in Patients with Squamous Cancer of the Head and Neck Undergoing Concurrent Treatment with Cetuximab and Radiotherapy

R. Mesía, A. Lozano, E. Vilajosana, 2009 .

Long-term outcomes of spinal SBRT. Is it important to select the treatment time?

O. Godino, A. Navarro-Martin, F. Guedea, 2021, Clinical and Translational Oncology.

Randomized phase 3 noninferiority trial of radiotherapy and cisplatin vs radiotherapy and cetuximab after docetaxel-cisplatin-fluorouracil induction chemotherapy in patients with locally advanced unresectable head and neck cancer.

B. Cirauqui, R. Hitt, S. Vázquez Estévez, 2022, Oral oncology.

Randomized placebo-controlled phase II trial of high-dose melatonin mucoadhesive oral gel for the prevention and treatment of oral mucositis in patients with head and neck cancer undergoing radiation therapy concurrent with systemic treatment

G. Escames, J. Giralt, R. Mesía, 2021, Clinical and Translational Oncology.

Late toxicity after radical treatment for locally advanced head and neck cancer.

R. Mesía, C. Hierro, J. Viñals, 2015, Oral oncology.

Residual neck disease management in squamous-cell carcinoma of the head and neck treated with radiotherapy plus cetuximab

R. Mesía, A. Rovira, R. Montal, 2016, Clinical and Translational Oncology.

Epidermal growth factor receptor (EGFR) pathway polymorphisms as predictive markers of cetuximab toxicity in locally advanced head and neck squamous cell carcinoma (HNSCC) in a Spanish population.

R. Mesía, E. Pérez-Ruiz, J. Fernández-Mateos, 2016, Oral oncology.

Repeat Thoracic Stereotactic Body Radiation Therapy (SBRT) for Nonsmall Cell Lung Cancer: Long-Term Outcomes, Toxicity, and Dosimetric Considerations

A. Hanlon, A. Ricco, R. Lanciano, 2020, Advances in radiation oncology.

The Use of HPV16-E5, EGFR, and pEGFR as Prognostic Biomarkers for Oropharyngeal Cancer Patients

L. Alemany, S. Tous, M. Alejo, 2018, Front. Oncol..

Ten-year experience of bone SBRT in breast cancer: analysis of predictive factors of effectiveness

M. Gil-Gil, A. García-Tejedor, F. Guedea, 2023, Clinical and Translational Oncology.

Adjuvant therapy with cetuximab for locally advanced squamous cell carcinoma of the oropharynx: results from a randomized, phase II prospective trial.

J. Carles, R. López-López, R. Mesía, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Could the Addition of Cetuximab to Conventional Radiation Therapy Improve Organ Preservation in Those Patients With Locally Advanced Larynx Cancer Who Respond to Induction Chemotherapy? An Organ Preservation Spanish Head and Neck Cancer Cooperative Group Phase 2 Study.

B. Cirauqui, J. García-Saenz, R. Mesía, 2017, International journal of radiation oncology, biology, physics.

Nutritional changes in patients with locally advanced head and neck cancer during treatment.

R. Mesía, N. Virgili, I. Peiró, 2017, Oral oncology.

932P Impact of geriatric assessment on the management of older head and neck cancer patients

M. Plana, R. Mesía, M. Taberna, 2020 .

Cetuximab may inhibit tumor growth and angiogenesis induced by ionizing radiation: a preclinical rationale for maintenance treatment after radiotherapy.

G. Capellá, A. Figueras, R. Mesía, 2010, The oncologist.

A Phase 2 Open Label, Single-Arm Trial to Evaluate the Combination of Cetuximab Plus Taxotere, Cisplatin, and 5-Flurouracil as an Induction Regimen in Patients With Unresectable Squamous Cell Carcinoma of the Head and Neck.

J. Carles, J. García-Saenz, R. Mesía, 2016, International journal of radiation oncology, biology, physics.

Validation of a prognostic model for predicting larynx preservation outcome (TALK score) in a Southern European population

B. Cirauqui, J. Vayreda, R. Mesía, 2023, Clinical and Translational Oncology.

Long-term outcome of radiotherapy-induced taste dysfunction in head and neck cancer patients: A pilot study

L. Giner, F. Guedea, A. Parra, 2020 .

A single-arm phase II trial to evaluate the combination of cetuximab plus docetaxel, cisplatin, and 5-fluorouracil (TPF) as induction chemotherapy (IC) in patients (pts) with unresectable SCCHN.

J. García-Saenz, R. Mesía, A. Irigoyen, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Proton Therapy for Unresectable and Medically Inoperable Locally Advanced Pancreatic Cancer: Results From a Multi-Institutional Prospective Registry

W. Regine, J. Urbanic, S. Apisarnthanarax, 2023, Advances in radiation oncology.

Epidermal growth factor receptor (EGFR) pathway polymorphisms as predictive markers of cetuximab toxicity in locally advanced head and neck squamous cell carcinoma (HNSCC) in a Spanish population.

J. Fernández-Mateos, M. Taberna, A. Lozano, 2016, Oral Oncology.

J. Carles, J. García-Saenz, R. Mesía, 2016, International journal of radiation oncology, biology, physics.